Table 3.
Study Blinding | Intervention | Control | Outcomes |
---|---|---|---|
Primary Total Hip Replacement | |||
Ilfeld33 Triple | CLPB until POD 4 | CLPB until POD 1 | WOMAC at 1, 2, 3, 6, and 12 months |
Primary Total Knee Replacement | |||
Ilfeld34 Triple | CFNB until POD 4 | CFNB until POD 1 | WOMAC at 1, 2, 3, 6, and 12 months |
Kadic35 Single | CFNB | No block | Knee function after 3 months (knee range of motion, KSS), WOMAC |
Nader36 Unblinded | CFNB Epidural infusion until POD 1 |
No block Epidural infusion until morning of POD 1 |
Knee flexion and functional outcomes at 1, 6, and 12 months |
Singelyn29 Unblinded | -CFNB -Epidural analgesia |
No block | Knee flexion at 6 weeks and 3 months postoperatively |
Tammachote37 Single | Periarticular infiltration | Intrathecal morphine | Knee flexion and Thai version of the WOMAC at 6 and 12 weeks |
Wu38 Unblinded | CFNB until POD 3 | No block | KSS (difference with preoperative value) at discharge, 6 weeks, 3 months, and 6 months postoperatively |
Zhang39 Double | Periarticular infiltration then ropivacaine/ketorolac infusion | Saline intraarticular infusion | Maximum knee flexion at 90 days |
CLPB, continuous lumbar plexus block; CFNB, continuous femoral nerve block; POD, postoperative day; KSS, Knee Society Score; WOMAC, Western Ontario and McMaster Osteoarthritis Index.